| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.0M | $4.0M | $3.0M |
| YoY Revenue Growth % | -23.9% | +30.7% | — |
| Gross Profit | $871.0K | $1.2M | — |
| Gross Margin % | 28.9% | 29.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$18.1M | -$12.5M | -$10.6M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$17.0M | -$11.8M | -$9.4M |
| EBITDA (Normalized) | -$18.1M | -$12.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$13.7M | -$8.2M | -$10.0M |
| Capital Expenditures (CapEx) | $56.0K | $53.0K | — |
| Free Cash Flow (FCF) | -$13.8M | -$8.3M | -$10.0M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $25.7M | $18.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $25.4M | $18.2M | — |